|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 48.41 USD | -4.04% |
|
-11.71% | -7.68% |
| Capitalization | 466.91Cr 401.77Cr 367.35Cr 350.49Cr 642.54Cr 45TCr 653.16Cr 4.41TCr 1.71TCr 21TCr 1.75TCr 1.71TCr 74TCr | P/E ratio 2026 * |
-10x | P/E ratio 2027 * | -12.8x |
|---|---|---|---|---|---|
| Enterprise value | 331.91Cr 285.61Cr 261.14Cr 249.15Cr 456.76Cr 32TCr 464.31Cr 3.13TCr 1.21TCr 15TCr 1.25TCr 1.22TCr 53TCr | EV / Sales 2026 * |
74.1x | EV / Sales 2027 * | 24.6x |
| Free-Float |
93.99% | Yield 2026 * |
-
| Yield 2027 * | - |
Last Transcript: CRISPR Therapeutics AG
| 1 day | -4.04% | ||
| 1 week | -11.71% | ||
| Current month | -7.51% | ||
| 1 month | -13.12% | ||
| 3 months | -8.78% | ||
| 6 months | -7.84% | ||
| Current year | -7.68% |
| 1 week | 48.25 |  | 56.16 |
| 1 month | 48.25 | | 58.6 |
| Current year | 44.12 | | 61.76 |
| 1 year | 35.38 | | 78.48 |
| 3 years | 30.04 | | 91.1 |
| 5 years | 30.04 | | 169.76 |
| 10 years | 11.63 | | 220.2 |
| Manager | Title | Age | Since |
|---|---|---|---|
Samarth Kulkarni
CEO | Chief Executive Officer | 47 | 01/12/2017 |
Raju Prasad
DFI | Director of Finance/CFO | 42 | 14/03/2023 |
Naimish Patel
CTO | Chief Tech/Sci/R&D Officer | - | 28/05/2024 |
| Director | Title | Age | Since |
|---|---|---|---|
Simeon George
BRD | Director/Board Member | 49 | 29/04/2015 |
Ali Behbahani
BRD | Director/Board Member | 49 | 01/04/2015 |
Samarth Kulkarni
CHM | Chairman | 47 | 15/09/2023 |
| Change | 5d. change | 1-year change | 3-years change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -4.04% | -11.71% | +24.86% | -21.54% | 466.91Cr | |
| -1.01% | -2.82% | -18.17% | -19.32% | 4.17TCr | |
| -3.73% | -6.04% | +28.41% | +22.76% | 3.26TCr | |
| -2.55% | +2.71% | +268.39% | +468.32% | 3.1TCr | |
| -0.91% | -5.37% | +18.41% | -11.55% | 2.82TCr | |
| -3.23% | -4.84% | +27.50% | +22.65% | 2.64TCr | |
| -2.03% | +0.77% | - | - | 1.49TCr | |
| +6.21% | -2.39% | +176.35% | +4,385.95% | 1.41TCr | |
| -1.92% | -1.95% | +121.19% | +106.25% | 1.23TCr | |
| -0.20% | -0.10% | +5.63% | -1.89% | 1.21TCr | |
| Average | -1.34% | -2.82% | +72.51% | +550.18% | 2.18TCr | |
| Weighted average by Cap. | -1.56% | -2.38% | +68.40% | +383.50% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 4.48Cr 3.85Cr 3.52Cr 3.36Cr 6.16Cr 429.64Cr 6.26Cr 42Cr 16Cr 203.95Cr 17Cr 16Cr 710.56Cr | 15Cr 13Cr 12Cr 11Cr 21Cr 1.44TCr 21Cr 141.53Cr 55Cr 682.86Cr 56Cr 55Cr 2.38TCr |
| Net income | -48Cr -41Cr -38Cr -36Cr -66Cr -4.6TCr -67Cr -452.23Cr -174.99Cr -2.18TCr -179.79Cr -175.94Cr -7.6TCr | -39Cr -33Cr -31Cr -29Cr -54Cr -3.73TCr -54Cr -366.98Cr -142.01Cr -1.77TCr -145.9Cr -142.78Cr -6.17TCr |
| Net Debt | -135Cr -116.17Cr -106.21Cr -101.34Cr -185.78Cr -13TCr -188.85Cr -1.27TCr -493.1Cr -6.15TCr -506.63Cr -495.77Cr -21TCr | -98Cr -85Cr -77Cr -74Cr -135.38Cr -9.44TCr -137.61Cr -928.57Cr -359.31Cr -4.48TCr -369.17Cr -361.26Cr -16TCr |
| Date | Price | Change | Volume |
|---|---|---|---|
| 15/26/15 | 48.41 $ | -4.04% | 19,78,747 |
| 14/26/14 | 50.45 $ | -4.36% | 16,64,361 |
| 13/26/13 | 52.75 $ | -0.15% | 9,24,858 |
| 12/26/12 | 52.83 $ | -2.18% | 9,73,699 |
| 11/26/11 | 54.01 $ | -1.50% | 13,17,773 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Equities
- CRSP Stock
Select your edition
All financial news and data tailored to specific country editions
MarketScreener is also available in this country: United States.
Switch edition